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1. Introduction 
The general thinking of quality control of the chiral drugs is that we need to conduct the 
research following the characteristic of the chiral drug besides principles already existing[1]. 
During the research, according to the way by which the chiral center being introduced, we 
should adopt the effective measurement to control the optical purity of chiral material and 
each step resultant; choose the appropriate way (direct or indirect) to prove the absolute 
configuration according to compound's unique feature as well as research foundation 
already existing such as its preparation craft, the comparison of structure confirmation, the 
literature data and so on.  
2. Synthesizing technology for chiral drugs 
Chiral drug is a kind of special chemical drug. Its particularity must be considered in the 
research except the guideline for chemical drug[2]. We need to pay more attention to the 
change of chiral center and the optical purity in the process momentarily. 
During the research, both the optical purity of the starting material and the control of the 
process are important, which may have effect to the final product. So the internal control 
standard should be established especially the control of the optical purity. According to the 
way by which the chiral center being introduced, we should adopt different method to control 
the optical purity of each intermediate material. Moreover, we should monitor the change of 
the configuration in the reaction by establishing the appropriate process control target. 
2.1 Route analysis for synthesizing technology of chiral drug  
As it was said in the guideline[3], both asymmetrical synthesis and the resolution have 
superiority to obtain chiral drug - although the selectivity is better and the optical purity of 
final product is higher, asymmetrical synthesis has more steps; on the contrary, the route of 
resolution method is shorter, but the chiral purity is not meet the requirement sometimes, 
especially when there are more than one chiral center exist in the drug. We can choose the 
rational method according to the feature in the actual application.  
For the process of asymmetric synthesis, we consult the relevant literature as much as possible 
before establishing the process, and adequately understand the mechanism, reaction 
conditions and stereoselectivity about the different reactions, then find out the corresponding 
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reaction. Because the steric hindrance of materials, some reactions have larger stereoselectivity, 
and the needed configuration may be the one that is obtained from the reaction. If the needed 
is not the predominance configuration or that is not ideal proportion, some measurement 
should be adopted to improve the reaction selectivity, introducing a large group into the 
starting material such as salt or ester, then improve greatly the stereoselectivity. For example, 
some chiral drug evaluating needs to form two chiral carbons, the researchers induce a tert-
butyl group to the starting material, after forming the chiral center, the inducing group is 
eliminated, the result confirm the inducing group that will improve the stereoselectivity from 
60% to 98%, then get high yield, and the sequent purification process had been simplified 
synchronously. The strategy to the synthesis such as figure 1.  
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Fig. 1. The strategy to the synthesis: improving the stereoselectivity 
In addition, the different reaction conditions such as temperature, pressure and the addition 
of special chiral catalysts may likely affect the stereoselectivity of the reaction, there are a lot 
of books and literature can be consulted, the test can be designed according to the actual 
situation and the literatures. It should be noted that the current use of some common chiral 
catalysts such as ruthenium, rhodium, etc have high toxicity, and so the strictly measurement 
should be adopted to control the residues of the mental catalysts. Identify of the limits can 
consult Guideline on the Specification Limits for Residues of Metal Catalysts or Metal 
Reagents issued by the EU EMEA[4]. 
2.2 Control of the starting materials 
The chiral starting materials, besides some common chiral materials like L-amino acids,  
D-tartaric acid, other chiral starting materials purchased from other companies should be 
established the corresponding chiral purity control item, and should be provided the 
production techniques and detailed quality control about it, evaluated the rationality of the 
process. In the actual evaluation, a lot of applicants did not provide the production 
techniques and detailed quality control about the chiral starting materials purchased, and 
did not carry out the optical control on the chiral starting materials, directly impact on the 
quality control of starting materials and the evaluation on its quality. For example: a 
purchased key side-chain has two chiral centers that is used in the synthesis of antilipemic 
drug Atorvastatin calcium by some applicants ( the structure described in Fig. 2 ), but the 
applicants don’t accomplish the corresponding chiral purity control item, that will affect on 
the evaluation of the drug application, and the drug standard doesn’t include the chiral 
quality index about the product, so that the application isn’t approved. 
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Fig. 2. The key side chains in the synthesis of Atorvastatin calcium 
And some applicants have already accomplished a rough chiral purity control item, such as 
controlling the optical rotation of the starting materials. but the control of optical rotation is 
not enough to ensure the high content of the optical isomerism, especially when the starting 
material contains two or more chiral centers, and the different chiral center will contribute to 
the addition of optical rotation, it’s not enough that only to utilize the optical rotation of the 
starting materials to afford a high content of steric isomerism. in addition, the range of the 
optical rotation is usually too rough, even if there is considerable quantity of of isomerism 
impurities, the optical rotation can still meet the requirement of the limit. For example, the 
optical rotation is usually controlled in the range ± 5° in the current specification, if a chiral 
drug contains one chiral center, even if there is only 5% enantiomers in the final product, the 
determination of the optical rotation traps in the range of the standard, and these should be 
limited more exacting than the limits. So if the optical rotation is used as a chiral purity 
control item, sufficient validation about its accuracy and precision should be made to ensure 
its confidence, and must be shown an accurate definition. There is a chiral drug with 
multiple chiral carbon atoms, because each chiral carbon atom contributes to the apparent 
optical rotation of the final product, then it will is more complex to calculate the optical 
rotation, here to control the optical purity through the optical rotation of the product will be 
more difficult. If a following chemistry reaction is achieved by the use of a low purity of the 
starting material, it will be more difficult to develop the sequent purification and quality 
control, and it will greatly increase the cost of the synthesis of final product. 
Based on those reasons, we suggested that appropriate optical purity guideposts about the 
chiral starting material should be established, and the chiral HPLC method should be used 
if necessary. In addition, it should provide detailed production process of chiral starting 
material and detailed quality control process to evaluate the rationality of the craft. 
2.3 Intermediates control  
In addition to the introduction of chiral centers from chiral starting materials, it may also be 
introduced during the reaction. We should focus on steps that generate chiral centers. The 
intermediate, which will generate the new chiral center, should be controlled and internal 
quality control standard should be established. After introducing this chiral center, possible 
stereomeride should be focused on and monitored. In order to fully control the optical 
purity of products, we should understand the reaction mechanism of introducing chiral 
center, analysis isomer structure and different isomer proportion; establish effective isomers 
separation control method. It could not only depend on refining to improve the optical 
purity of final products. It needs to note that if this starting material used containing more 
than one chiral center, and this step reaction did not affected other chiral center, then this 
step reaction formed the diastereoisomer which could be separated by the ordinary HPLC 
methods. This requires adequate method validation. By those, we could control such key 
intermediates effectively intermediates. 
www.intechopen.com
 
Quality Control of Herbal Medicines and Related Areas 
 
164 
2.4 Process control and process control index  
Comparing with non-chiral drugs, in-process control is very important in synthesizing of 
chiral drugs, especially when the chiral drugs containing more than one chiral center. Each 
step stereoisomer impurities should be detected, analyzed and possibility of conformational 
changes be monitored, rather than using an ordinary HPLC monitoring method or TLC 
method. 
Optimizing reaction parameters, monitoring the optical purity of reaction products could 
help us to determine this step reaction process condition and reaction products optical 
purity control item. After the introduction of chiral centers, follow-up reaction can make 
configuration changes. According to the difficulty of the final product quality control, 
different control methods were used to control the optical purity of the final product. 
During the process research, the stereoisomers of impurities were detected after the 
introduction of chiral centers in each step, the possibility of conformational changes were 
analyzed and monitored. If there were no configuration changes, it should strictly control 
the process parametersits in the preparation process according to the results of process 
optimization and verification. If such changes may occur, indicators should also be targeted 
using the optical purity of the intermediate control, in addition to strictly control the process 
parameters. 
With the reaction mechanism in each step and possible side effects, we should 
comprehensive analysis the stereoisomers structure of impurities, determine the scope of the 
possible structure of impurities, and to verify the method of structural confirmation. So to 
reduce the work load of the impurities structure confirmation. For example, an innovative 
chiral drug, the reaction generated 4 diastereoisomer in step; these isomers were isolated 
and determined by NMR spectra. Combined with the reaction principle and the theoretical 
values determined different isomers structure were confirmed, and the formation of these 
isomers ratio of process parameters were optimized, and also provides a strong proof to the 
confirmation of the final product structure. 
3. Characterisation research of chiral drugs  
3.1 The general principles to the structure identification of chiral drugs 
During the study of structural confirmation of chiral drugs, it should not only be 
consistent with the general principles of structural confirmation, but also pay particular 
attention to the research and conclusive evidence of configuration according with the 
requirements of the guiding principles. For innovative chiral drugs, chiral centers on the 
absolute configuration should be confirmed clearly; for generic drugs absolute 
configuration should be confirmed with orignal drugs. Since enantiomers have the same 
general physical and chemical properties, chromatographic retention behavior (non-chiral 
packing column) and spectral characteristics (IR, Ultraviolet spectrum, nuclear magnetic 
resonance (NMR) spectroscopy, mass spectrometry), so the conventional method can not 
corroborate the configuration of chiral drugs, even if the conventional structure 
comparison with the configuration of standard product, still can’t confirm their stereo 
configuration. In the actual evaluation about chiral drugs, we can often see that some 
drugs have multiple chiral carbons, but the applicants work over only by the four 
conventional spectrum analysis methods in the structure corroboration, not for chiral 
center,which causes the supplement rate of these drugs higher than the normal drugs in 
the structure corroboration.  
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It should be known that, the methods of structure corroboration about chiral drugs are 
classified, and the main method of configurational corroborating respectively is introduced, 
which are comprehensive. The methods concreted and their principles may refer to the 
guiding principle and relevant professional books, which are not mentioned in this no 
longer. In the following, only the questions found in the structure corroboration and the 
specific application of various methods will be stated. 
3.2 The direct methods  
Single-crystal X-ray diffraction method belongs to the direct methods, and is the preferred 
method of configuration corroboration about chiral drugs. The indirect methods need a lot 
of jobs to do, especially in corroborating innovative drug configuration or in the drugs of 
multiple chiral centers. but the single-crystal X-ray diffraction method can provide directly 
configuration information. So we should get the drug samples of single crystal 
determination of single crystal X-ray diffraction as far as possible through various measures. 
Of course, if the indirect method is simple, and can be relatively easy to identify the absolute 
configuration, there is no need to perform the single crystal determination. The point need 
stressed is that the object of single-crystal X-ray diffraction structure analysis only to be one 
crystal among the samples to be measured, which will not be representative. So it is 
necessary that the drug samples will be measured with powder X-ray diffraction, and gets 
the theoretical powder X-ray diffraction spectrum of chiral drugs through the calculation of 
single crystal structure data., and then is compared with that of sample drugs powder. The 
single-crystal sample will be proved to be representative when two crystal diffraction 
spectrums are consistent, and then corroborate configuration of the chiral drugs. Although 
the point is stressed in this guiding principle, but the declaring enterprises all do not have a 
research about this, which can cause evaluation personnel some questions, ever if some 
samples have a detection of the single-crystal X-ray diffraction. So attention must be brought 
to the applicants. 
3.3 The indirect methods  
When it is difficult to raise single crystal, more indirect combined application methods 
should be made. Usually, an indirect method to identify the absolute stereo configuration is 
limited, should as far as possible use more than one indirect methods to mutual self-evident. 
In the following, the application of indirect methods will be introduced though some 
examples in the evaluation. 
3.3.1 The specific rotation  
For the chiral drug only containing a chiral center, such as Levocarnitine, (S)-Amlodipine, its 
stereo configuration can be determined by rotation detection and enantiomer control. If the 
result of rotation detection is consistent with literature value, and the enantiomer can be 
generally effective controlled in the quality standards, the chiral drugs’ stereo configuration 
may be identify in according to the conventional method. But if the chiral drugs are 
innovative drugs, their absolute configuration should still be corroborated. 
3.3.2 Chiral HPLC positioning method and specific rotation 
For the chiral drug containing two chiral centers, such as Sertraline Hydrochloride, it has a 
enantiomer and two diastereomers. These isomers can be separated and positioned through 
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chiral HPLC conditions in the reference when their configuration are corroborated. 
According to the result of specific rotation detection, we affirm that its configuration would 
be consistent with the marketed drug if they have the same chromatograms. If marketed 
standard substance to be available, we affirm that its configuration would be consistent with 
the marketed drug through the way combining chiral HPLC method with NMR 
spectroscopy. 
 
NH2CH3 HCl.
 
Fig. 3. Sertraline Hydrochloride 
3.3.3 Literature comparative method  
For the chiral drug containing multiple chiral centers, the determination of other items must 
be detected in order to corroborate three-dimensional structure of every chiral center 
besides specific rotation detection. For these compounds, the literature data obtained 
outside is also very important, except for the methods mentioned in this guiding principle of 
direct or indirect method. Because of multiple chiral centers, the presence of the final 
product including enantiomers are less, rather than non-enantiomers in the NMR spectrum 
are obvious differences, through the literature data by comparison with the measured data 
confirm the stereochemistry. Such as the muscle relaxant Vecuronium Bromide (Figure 4),   
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Fig. 4. Vecuronium Bromide 
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the structure contains ten chiral carbon, but one of the six chiral carbon in a rigid steroid 
ring, in the subsequent reaction of steroid body chiral carbon on the ring flip is unlikely 
occurrence, follow-up of non-response is only possible non-enantiomers. The literature clearly 
shows the various possible non-enantiomers of the NMR data and maps, which compare the 
sample through the NMR measured values with the literature, combined with other 
evidence of testing to confirm the relatively easy three-dimensional product configuration. 
3.3.4 The inverse method of intermediate configuration  
The determination of the intermediate single crystal X-diffraction is significant to the 
determination of the structure of the final product. Sometimes, the end product of the single 
crystal can not be obtained. At the same time, they can study and explore the availability of 
the last step reaction of the intermediate 1,2-crystal. When the intermediates of single crystal 
can be obtained, and chiral center does not changes or changes in control centers in the 
subsequent reaction, these intermediate configuration of the confirmation of the final 
product configuration is the very useful evidence for confirmation. such as the Chiral drug 
A, its single crystal is not available. But the intermediate steps before a chiral drug  
L-Menthylacetat single crystal is available, through its configuration can be anti-speculation 
chiral drug A by the conclusive evidence, shown in Figure 5. 
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Chiral drug A-3-L-Menthylacetat  
Fig. 5. Anti-speculation process 
3.3.5 NMR  
NMR is useful to the confirmed of general structure of the drug. But he confirmed of the 
structure of chiral drugs has serious limitations, because the isotropic probe in the NMR 
determination is connatural. It makes the map of measured isomer NMR spectrum is 
identical. If distinguished by NMR mapping isomers, enantiomers shoud be changed into 
diastereoisomers, and then receive the appropriate tests. The methods of Common detection 
include: adding chiral shift reagent, add chiral solvent and chiral derivatization method and 
so on. After adding chiral derivatization reagent, it can make the formation of chiral drugs 
covalent bond. Then though the determination of NMR spectra, it can effectively distinguish 
different enantiomers with the configuration of the end product. This method is in common, 
and the different structure of chiral drugs can have a variety of derivatization reagent for 
selection. Referring to the specific relevant professional books, the guidelines are an increase 
Mosher Law adding chiral derivatization method. 
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3.3.6 Theoretical analysis & NMR 
Reasonable theoretical analysis for the validation of the configuration of the final product is 
important. When a chiral drug in the chiral center from the starting material or reagent 
introduced, and the chiral centers in the subsequent reaction is not affected, or the 
configuration of chiral center of the quantitative impact is clearly occurring At this point, if 
the starting materials or reagents of three-dimensional structure is known, by classical 
chemical correlation method can be confirmed in the API configuration of chiral centers. 
Such as cisatracurium besylate (structure shown in Figure 6) confirmed the structure of the 
drug exists in four chiral centers, configuration is 1R, 1'R, 2R, 2'R type, and its structure 
confirmed by theoretical analysis and nuclear magnetic resonance methods: the synthesis of 
this product to R-Tetrahydropapaverine synthesized R-Tetrahydropapaverine does not 
involve the chiral carbon papaverine chiral reversal, the basic validation of 1,1 '-bit 
conformation; 2,2 '-bit configuration determined using NOESY spectra, NOESY spectra of 
C1-bit display connected to the methylene on the benzyl hydrogen and N2 connected 
propionate methylene hydrogen are related, but and N2-methyl hydrogen does not exist on 
the relationship, indicating that the connection C1 and N2 connected benzyl propionate in 
the cis part of the basic goods can confirm the stereochemistry. 
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Fig. 6. Cisatracurium besylate 
In addition, impurities can be combined with process research and study results to 
determine the configuration of end products, such as some examples in the Technology 
Application Unit of which the results of theoretical synthesis of the four possible isomers 
were separated and identified, but also for configuration of the main components of the 
quality of the establishment and follow-up study provides strong evidence.  
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